Eva Medtec (2023)

About this raise

Eva Medtec, with a valuation of $11,030,000, is raising funds on Startengine. They make it possible for anyone to experience the benefits of automated lymphatic therapy with one simple, at-home system. Eva Medtec is targeting the $4B Pain Management Devices market. They have created and manufactured Neuroglide™, an over the counter, FDA-cleared medical device engineered to automate and emulate manual lymphatic drainage (MLD) therapy. Irene Waldridge founded Eva Medtec in 2016. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,234,999. The campaign proceeds will be used for company employment, inventory, working capital and clinical studies.

Expand

Investment Overview

Invested this round: $130,534

Deal Terms

Total Commitments

Platform
StartEngine
Start Date
12/20/2022
Close Date
03/20/2023
Min. Goal
$9,999
Max Goal
$1,235,000
Min. Investment

$299

Security Type

Equity - Common

Company Stage

Early Stage

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.49

Pre-Money Valuation

$11,030,000

Company & Team

Company

Year Founded
2016
Industry
Healthcare & Pharmaceuticals
Tech Sector
Medtech
Distribution Model
B2C
Margin
Low
Capital Intensity
High
Location
Bloomington, Minnesota
Business Type
Growth
Company Website
Visit Website

Team

Employees
4
Prior Founder Exits?
No
Founder Name
Irene Yarusso Waldridge
Title
CEO

Financials

 Revenue
$68,149
as of FY2021
 Monthly Burn
$73,758
as of FY2021
 Runway
0.3 months
as of FY2021

Summary Profit and Loss Statement

FY 2021 FY 2020

Revenue

$68,149

$0

COGS

$75,458

$0

Tax

$0

$0

 

 

Net Income

$-885,098

$-794,843

Summary Balance Sheet

FY 2021 FY 2020

Cash

$20,486

$253,766

Accounts Receivable

$0

$0

Total Assets

$473,507

$603,758

Short-Term Debt

$147,154

$120,854

Long-Term Debt

$50,000

$31,214

Total Liabilities

$197,154

$152,068

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$1,014,500
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
03/05/2025 Andes Capital $22,626,135 $0 Equity - Common Not Funded RegCF
06/30/2023 Netcapital $8,997,823 $0 Equity - Common Not Funded RegCF
03/20/2023 StartEngine $11,030,000 $130,534 Equity - Common Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.

Growth Charts

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Eva Medtec on StartEngine 2022
Platform: StartEngine
Security Type: Equity - Common
Valuation: $11,030,000
Price per Share: $1.49

Follow company

Follow Eva Medtec on StartEngine 2022

Buy Eva Medtec's Deal Report

Warning: according to the close date for this deal, Eva Medtec may no longer be accepting investments.

Eva Medtec Deal Report

Get Kingscrowd's comprehensive report on Eva Medtec including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Eva Medtec is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Eva Medtec deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge